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Abstract
The off-pump literature is divided into three eras: the “early phase” with results favouring off-pump surgery supported
with randomized control trials (RCTs) mainly from Bristol, UK; an “intermediate phase” dominated by the results of the
ROOBY trial and finally a more “contemporary phase” whereby the off/on-pump argument is unsettled. Although the
literature has failed to project an overall superiority of off-pump versus on-pump surgery, nevertheless, small randomized
control trials and large meta-analysis studies are concluding that the incidence of a stroke is less than 1 % when an aortic
off-pump techniques (especially the non-touch technique) are advocated in patients with diseased ascending aorta.
Furthermore, off-pump combined with hybrid procedures may lead to a reduction of adverse outcome in the aged high-
risk population with concomitant poor left ventricular function and co-morbidities.
The current review attempts to bring an insight onto the last ten years knowledge on the on/off-pump debate, with an
aim to draw some clear conclusions in order to allow practitioners to reflect on the subject.
Keywords: Off-pump coronary surgery, Coronary artery bypass surgery, beating heart surgery, RCTs in off-pump surgery,
Off-pump versus on-pump
Background
Most surgeons perform coronary bypass surgery with the
aid of cardiopulmonary bypass, which (at least in theory)
inflicts a massive systemic inflammatory response to the
body, leading to adverse clinical outcome.
In an attempt to make coronary bypass less invasive,
interest have been diverted to the off pump technique.
In the initial phase of off pump surgery, the procedure
was performed without mechanical stabilizers and was
borne out of cost containment. However, the off pump
technique was technically challenging and limited to few
surgeons only. With the introduction of mechanical stabi-
lizers, off pump techniques are now technically less
challenging and allow access to all sides of the heart for
meticulous coronary anastomosis. Despite this, contro-
versy still exists among the cardiac surgery community re-
garding the outcome, benefits and safety of this technique;
In this review, we invite the reader to take a stroll
through the publishing knowledge on “off pump” coron-
ary surgery; in this respect, we take the opportunity to
examine and reflect on to what we have learnt from the
current literature on the subject.
Important Randomized Control Trials (RCTs)
There are only few RCTs through out the literature that
compare on pump versus off pump coronary surgery.
Angelini et al. [1] randomized 401 patients over a 2 year
period (1997-1999); randomly allocated 200 patients to
off-pump and 201 to on-pump coronary surgery. They
excluded patients who had had myocardial infarction in
the past month or who required grafting of the circumflex
artery distal to the first obtuse marginal branch. In a sub-
sequent study (BHACAS 2) [2] the previously excluded
patients (from BHACAS 1) were also studied; the authors
showed an improved short-term outcome with off-pump
(reduced intubation time, ITU stay, inotropes require-
ments, blood loss/ transfusion requirements, AF, pneumo-
nia, hospital stay) and similarly a favourable medium term
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outcome 1-3 years postoperatively. Overall, 10.8 % of
grafts were occluded across both groups. Further, logis-
tic regression analysis showed no evidence that grafts
were more likely to be occluded in Off-pump than in
On-pump patients.
The differences in MACE-free survival and quality of
Life indicators did not approach statistical significance. Al-
though these findings greatly bolstered the case of the
proponents of Off-pump surgery, some shortcomings
pointed out were that the modality of assessment of graft
patency was non-invasive (Coronary multi-sliced CT) as
against the gold standard of coronary angiography; also,
the study was a single centre study by a single surgical
team, and hence could not necessarily be extrapolated to
other surgeons and centres. Another concern with those
studies was the fact that only a small number of patients
were enrolled; To tighten confidence limits and prove that
off-pump is safer would require a significant number of
patients to improve power. However, BHACAS remains
one of the early important randomized series with the
longest-follow up data available.
The long-term patency was studied with Coronary
multi-sliced CT [3]. The likelihood of graft occlusion was
no different between off-pump coronary artery bypass
(10.6 %) and coronary artery bypass grafting with cardio-
pulmonary bypass (11.0 %) groups (odds ratio, 1.00; 95 %
confidence interval, 0.55–1.81; P >0.99).
Nathoe et al. [4] randomized 281 low risk patients (only
1 or 2 vessel disease; excluded recent MI, poor LV) and
found less transfusion requirements and less CKMB
release. Clinical outcome was similar at 1 year. In a sub-
group of patients where angiography was performed, pa-
tency at 1 year was similar, however off-pump was cost-
effective: 14 % cheaper at 1 year.
Puskas et al. [5] randomized (SMART study) 200 unse-
lected patients excluding reoperations, patients in car-
diogenic shock or patients who had preoperative IABP
insertion. Complete revascularization was achieved in
both groups. There was shorter hospital stay, reduced
blood loss and transfusion, reduced levels of cardiac en-
zymes (CKMB and TnI) in the off-pump group. Early
hospital outcome was similar. This article highlights that
completeness of revascularization was achievable in off-
pump. Coronary angiography prior to hospital discharge on
93.4 % of enrolled patients was carried out and showed
similar patency (99.0 % off-pump v. 97.7 % on-pump).
Angiography at 1-year [6] in153 patients showed similar
patency (93.6 % Off-pump v. 95.8 % On-pump). There was
no difference in clinical outcome: Rates of death, stroke,
myocardial infarction, angina, and re-intervention were
similar at 30 days and 1 year. This paper serves as a useful
reference for angiographic patency at 1 year. Furthermore
in a late follow up by the same authors [7] 190 grafts
assessed by computed tomographic angiography with
comparable patency. At late follow-up, recurrent angina
had occurred in 25.6 % of off pump patients and 11.4 % of
the on pump patients (p = 0.09).
Legare et al. [8] randomized 300 patients with EF > 30 %
and found no differences in mortality, MI, stroke, transfu-
sion, Atrial Fibrillation, time to extubation, ITU stay and
hospital stay. This paper serves as a useful reference for
the possible “lack of beneficial outcome” of off-pump cor-
onary surgery, especially in low-risk patients.
Angiographic outcomes of Off pump surgery were re-
ported by Al-Ruzzeh et al. [9] on a randomized population
of 168 patients; Graft patency was evaluated by angiog-
raphy at 3 months and was similar between the on-pump
and off-pump groups. Patients in the off-pump group re-
quired fewer blood transfusions (1.7 units v 1.0 unit, P =
0.02), shorter duration of mechanical ventilation (7.7 hours
v 3.9 hours, P = 0.03), and shorter hospital stay (10.8 days
v 8.9 days). Scores for neurocognitive function showed a
significant difference in three memory subtests at six
weeks and two memory subtests at six months in favour
of the off-pump group.
The ROOBY trial [10] recruited 2203 patients random-
ized to on versus off–pump (on-pump (n = 1,099) or off-
pump (n = 1,104) procedures). It is noteworthy that this
trial is by far the largest RCT comparing the effects of
on and off pump surgery.
The primary short-term end point was a composite of
death or complications (reoperation, new mechanical
support, cardiac arrest, coma, stroke, or renal failure)
before discharge or within 30 days after surgery. The
primary long-term end point was a composite of death
from any cause, a repeat revascularization procedure, or
a nonfatal MI within 1 year after surgery. Secondary end
points included the completeness of revascularization,
graft patency at 1 year, neuropsychological outcomes,
and the use of major resources.
The authors reported no significant difference in 30-day
mortality between the off-pump group and the on-pump
group (2 % [18/1104] and 1 % [13/1099] respectively, p =
0.47). The proportion of patients with fewer grafts than
originally planned, was higher with off-pump CABG than
with on-pump CABG (17.8 % vs. 11.1 %, P < 0.001).
Follow-up angiograms in 1371 patients who underwent
4093 grafts revealed that the overall rate of graft patency
was lower in the off-pump group than in the on-pump
group (82.6 % vs. 87.8 %, P < 0.01). There were no differ-
ences in cognitive function, as well as no neurological dif-
ferences were noted between the two groups at one year.
Survival post surgery up to 2000-days was slightly lower
in the off pump treatment group.
The ROOBY trial received criticisms: firstly, the pa-
tients enrolled were almost exclusively males; secondly
there was a trend toward enrolling lower-risk patients
and excluding higher-risk.
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During trial recruitment period, 9663 patients who were
scheduled for urgent or elective CABG were screened for
enrolment, 7460 patients (77.2 %) were excluded; 2716 pa-
tients because of diffuse disease or small coronary arteries,
2461 because of unavailability of a participating surgeon
or study coordinator, or patient refusal or inability to par-
ticipate in 1467 patients.
Lastly, the ROOBY trial was criticized for the fact that
the conversion rate to Cardio pulmonary bypass was
unacceptably high at 12 % and this brought some scepti-
cism on the level of “off pump” experience of the surgeons
involved in the study.
An RCT on high risk patients, defined as EuroSCORE ≥5
undergoing on versus off-pump surgery was reported by
Moller et al. ([11]. 341 patients with 3-vessel coronary dis-
ease were recruited. The primary outcome was a composite
of adverse cardiac and cerebrovascular events. Exclusion
criteria were previous heart surgery, left ventricular ejection
fraction <30 %, lack of informed consent, and unstable pre-
operative condition. Fewer grafts were performed to the lat-
eral part of the left ventricle territory during off-pump
surgery (0.97 versus 1.14 after on-pump surgery; P = 0.01).
Eight patients (4.5 %) allocated to off-pump CABG crossed
over to on-pump CABG. There were no significant differ-
ences in the composite primary outcome (15 % versus
18 %; P = 0.48). The 3-year follow up [12] of this trial
showed that MACCE occurred in 40 % patients allocated
to off-pump versus 33 % of the patients allocated to on-
pump CABG. All-cause mortality was significantly in-
creased in the off-pump group (24 % versus 15 %; HR 1.66,
95 % CI 1.02 to 2.73; p = 0.04), but cardiac-related death
was not significantly different (10 % versus 7 %; HR 1.30,
95 % CI 0.64 to 2.66; p = 0.47). The authors concluded that
the mortality was higher following off-pump surgery. How-
ever, this trial cannot provide any answers on the potential
benefit or harm that off-pump coronary artery bypass graft
surgery may have on patients with ejection fraction <30 %,
those who are undergoing redo coronary artery bypass graft
surgery, or those patients in an unstable preoperative con-
dition/emergency operation. With other words, the patients
recruited in this trial were marginally high-risk population
and therefore the lack of significant difference in the out-
come was predictable; furthermore an-aortic technique was
not employed in this group of patients.
Houlind et al. [13] (The DOORS trial) set off to deter-
mine graft patency between on and off pump surgery,
with post operative angiography: In a randomized, con-
trolled, multicenter trial, 900 patients more than 70 years
of age received either on-pump or off-pump coronary
artery bypass surgery. A total of 481 patients underwent
angiography. In the off-pump group, 561 (79 %) of 710
grafts were open, 65 (9 %) were stenotic, and 84 (12 %)
were occluded. In the on-pump group, 549 (86 %) of 650
grafts were open, 38 (5 %) were stenotic, and 63 (9 %)
were occluded. The difference between the proportions
of open grafts was statistically significant in favour of
on-pump surgery (P = .01).
The future is exciting with a number of RCTs on the
way:
CORONARY [14] is the largest RCT yet conducted
comparing off-pump CABG to on-pump CABG. The
plan was to randomize 4,700 patients to on or off pump.
The co-primary outcomes are a composite of total mor-
tality, myocardial infarction (MI), stroke, and renal fail-
ure at 30 days and a composite of total mortality, MI,
stroke, renal failure, and repeat revascularization at
5 years. As of May 3, 2011, CORONARY has recruited
3,884 patients from 79 centres in 19 countries. Cur-
rently, patient’s mean age is 67.6 years, 80.7 % are men,
47.0 % have a history of diabetes, 51.4 % have a history
of smoking, and 34.4 % had a previous MI. In addition,
20.9 % of patients have a left main disease, and 96.6 %
have double or triple vessel disease. Finally 4752 patients
were recruited [15], and early results published in 2012.
There was no significant difference between off-pump and
on-pump CABG with respect to the rate of death, nonfatal
myocardial infarction, nonfatal stroke or renal failure
requiring hemodialysis at 30 days after randomization.
Subgroups analysis of 244 patients with ejection fraction
between 20-34 % showed that there was no significant
difference concerning the co-primary outcome (Hazard
Ratio: 0.91(0.47-1.74), p = 0.77).
However, the off-pump techniques significantly re-
duced the rate of blood-product transfusion (50.7 % vs
63.3 %; P < 0.001), reoperation for perioperative bleed-
ing (1.4 % vs 2.4 %; P = 0.02), acute kidney injury
(28.0 % vs 32.1 %; P = 0.01), and respiratory complica-
tions (5.9 % vs 7.5 %; P = 0.03) but increased the rate of
early repeat revascularizations (0.7 % vs 0.2 %; P = 0.01).
The authors attributed the overall encouraging short-
term benefits to the high level of expertise and technical
skills for participating surgeons and their abilities to sat-
isfactorily manage the inherent difficulties in performing
delicate anastomoses on a beating heart and yet attain a
near-equal level of complete revascularization in the off-
pump surgery group as compared with the on-pump
surgery group (88.2 % vs 90 %, respectively; P = 0.05).
At 1 year [16], there was no significant difference in
the rate of the primary composite outcome between off-
pump and on-pump CABG (12.1 % and 13.3 %, respect-
ively; hazard ratio with off-pump CABG, 0.91; 95 % con-
fidence interval [CI], 0.77 to 1.07; P = 0.24). The rate of
the primary outcome was also similar in the two groups
in the period between 31 days and 1 year (hazard ratio,
0.79; 95 % CI, 0.55 to 1.13; P = 0.19). The rate of repeat
coronary revascularization at 1 year was 1.4 % in the off-
pump group and 0.8 % in the on-pump group (hazard
ratio, 1.66; 95 % CI, 0.95 to 2.89; P = 0.07). There were
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no significant differences between the two groups at
1 year in measures of quality of life or neurocognitive
function.
The GOPCABE trial [17] had randomly assigned patients
75 years of age or older who were scheduled for elective
first-time CABG on or off pump. The primary end point
was a composite of death, stroke, myocardial infarction, re-
peat revascularization, or new renal-replacement therapy at
30 days and at 12 months after surgery. A total of 2539 pa-
tients underwent randomization. At 30 days after surgery,
there was no significant difference between patients who
underwent off-pump surgery and those who underwent
on-pump surgery in terms of the composite outcome
(7.8 % vs. 8.2 %; odds ratio, 0.95; 95 % confidence interval
[CI], 0.71 to 1.28; P = 0.74) or four of the components
(death, stroke, myocardial infarction, or new renal-
replacement therapy). Repeat revascularization occurred
more frequently after off-pump CABG than after on-pump
CABG.
The criticism to this trial includes several points:
1) The need for intra operative graft assessment, since it
is known that surgical revision may be necessary in
certain cases. Such assessment is not mentioned in
this report. In addition, antithrombotic management
is not reported. This lack of standardization in the off-
pump CABG group is a limitation and may explain
why repeat revascularization was the only significant
difference (1.3 % vs. 0.4 %; odds ratio, 2.42; 95 % CI,
1.03 to 5.72; P = 0.04).
The GOPCABE trial goes on to report that at
12 months, there was no significant between-group dif-
ference in the composite end point (13.1 % vs. 14.0 %;
hazard ratio, 0.93; 95 % CI, 0.76 to 1.16; P = 0.48) or in
any of the individual components. Similar results were
obtained in a per-protocol analysis that excluded the 177
patients who crossed over from the assigned treatment
to the other treatment.
2) The authors should have presented an “as-treated”
analysis (not as intention to treat) based on the
operation actually performed, and the patients who
crossed over from the assigned treatment should not
have been excluded.
3) 37 high-risk patients crossed over to off-pump
CABG because of a calcified ascending aorta, the
stroke rate was still high among patients who
underwent off-pump CABG (2.2 %). It is estab-
lished that systematic application of “anaortic”
techniques (i.e., off-pump CABG without aortic
manipulation) reduces the rate of stroke to less
than 1 %, 2-4 but no information about aortic man-
agement was provided.
The MASS III trial [18] was a single-centre study that
evaluated 308 patients with multivessel coronary artery
disease randomized to on-pump (153) or off-pump (155)
CABG. Of this total, 260 (84.4 %) patients had, on cor-
onary angiography, at least one 70 % obstruction in the
circumflex territory (141 on-pump and 119 off-pump).
The combined outcome was death, myocardial infarc-
tion, target vessel revascularization (angioplasty or
surgery) or hospitalization for cardiac causes. After
5 years of follow-up, off-pump CABG had higher com-
bined events than on-pump had: 25 (21 %) versus 17
(12 %), hazard ratio 1.88, 95 % confidence interval 1.02-
3.48, P = 0.041. In the multivariate model with the inclu-
sion of the following variables: age (P = 0.09) and
complete revascularization (P = 0.68), off-pump surgery
remained as a predictor of combined events in 5 years,
P = 0.03.
Treatment impact on diabetic patients (in 835 patients
at the ROOBY trial) randomized to received off-pump
CABG (n = 402) or on-pump CABG (n = 433) was
reported by Shroyer et al. [19]. For diabetic patients, the
primary short-term composite outcome rate showed a
worse trend for off-pump (8.0 %) than on-pump (3.9 %, p
= 0.013), with no difference in the 1-year primary compos-
ite outcome or 1-year death rate. One-year patency was
83.1 % off-pump versus 88.4 % on-pump (p = 0.004). No
differences were found in neurocognitive, health-related
quality of life, discharge cost, and 1-year cumulative cost.
Finally, only extended follow-up of existing random-
ized trials and new well-designed randomized trials to-
gether with cumulative meta-analysis of such trials will
yield robust evidence on the off-on pump argument.
“Important” Large Observational studies
Cleveland et al. [20] reported the early experience of the
STS National Database from 1998 - 1999. In that ana-
lysis, 106,423 patients underwent on-pump surgery and
11,717 patients underwent off-pump. The latter group
was more likely to be older, female, and have more
chronic obstructive pulmonary disease and renal failure.
On-pump patients were more likely to be diabetic, have
3-vessel or left main disease, or require emergency oper-
ation. Risk-adjusted mortality favoured off-pump (2.31 %
versus 2.93 %, P = 0.0001).
Off-pump patients had fewer strokes (2.5 % versus
4.6 %, P =0.0001), less prolonged mechanical ventilation
(8.9 % versus 11.3 %), less re-exploration for bleeding
(2.1 % versus 2.8 %), and shorter postoperative length of
stays (6.1 versus 7.0 days).
A report of the New York State Database [21] from
1997 to 2000 analyzed 59,044 on-pump and 9135 off-
pump patients. There was significantly greater propor-
tion of older patients, women patients with previous
stroke as well as renal failure, in the off-pump group.
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Even though the risk-adjusted operative mortality rate
for off-pump was lower (2.02 % versus 2.16 %) it did not
reach statistical significance. Off-pump patients did have
less stroke rate (1.6 % versus 2.0 %, P = 0.0003), and re-
operation for bleeding (1.6 % versus 2.2 %, P = 0.0001),
as well as shorter postoperative length of stay (5 versus
6 days, P = 0.0001). Improved survival at 3-year follow-
up in the on-pump group (89.5 % versus 88.8 %, P =
0.022) may have been affected by the older, sicker off-
pump patient’s profile.
Mack et al. [22] published a large retrospective series
consisting of 17,548 patients with multi-vessel disease
(from 4 centres over a 3-year period) matched by propen-
sity scoring (7200 off pump Vs. 11000 on pump). In this
study, the authors found that the mortality was sig-
nificantly less in the off-pump coronary artery bypass-
grafting group (2.8 % versus 3.7 %, P <0.001). They
concluded that the use of CPB was a predictor of
overall mortality (OR 2.08) and also of mortality in
re-operations (OR 3.37), female patients (OR 1.7) and
patients over 75 years (OR 2.13). Furthermore, they also
reported that off-pump is associated with reduced short-
term morbidity reductions in blood transfusion (32.6 % ver-
sus 40.6 %, P <0.001), stroke (1.4 % versus 2.1 %, P =0.002),
renal failure (2.6 % versus 5.2 %, P < .001), pulmonary com-
plications (4.1 % versus 9.5 %, P < .001), re-operation (1.7 %
versus 3.2 %, P < .001), atrial fibrillation (21.1 % versus
24.99 %, P < .001), and gastrointestinal complications (3.6 %
versus 4.8 %, P = .02). ). This was a short-term observational
study with no mid/long term follow up. However, this
serves as a good reference for potential usefulness of off-
pump in re-operations and elderly patients.
Hannan et al. [23] reported on New York State pa-
tients who underwent either off-pump (13 889 patients)
or on-pump CABG surgery (35 941 patients) between
2001 and 2004. An experience off-pump surgeon per-
formed two thirds of the off-pump cases. A total of 226
patients (1.63 %) were converted from off pump to on-
pump CABG, and their in-hospital mortality rate was
9.73 %. Off pump had a significantly lower inpatient
mortality rate (adjusted OR 0.81) and lower rates for
two peri-operative complications (stroke: adjusted OR
0.70, 95 % CI 0.57 to 0.86; and respiratory failure: ad-
justed OR 0.80, 95 % CI 0.68 to 0.93). However off pump
was associated with lower freedom from subsequent re-
vascularization, 89.9 % Vs. 93.6 % (P < 0.0001).
A large non-randomized trial was reported at the STS,
2009 [24]. The authors used the power of the STS data-
base to provide direct comparison between on-pump
and off- pump surgery. To remove the bias of low-
volume centre or surgeons and allow a critical look at
the results of each technique in relatively experienced
hands, they limited the analysis to centres that per-
formed at least 150 off-pump and 150 on-pump cases
over a 3-year period. This resulted in a study group of
186,458 patients. Of that cohort, 65,864 underwent off-
pump, whereas 120,594 underwent on-pump surgery.
They further analyzed patients by coronary anatomy,
grouping patients with 1 or 2 diseased vessels (45,969
patients), 3 diseased vessels without left main stenosis
(97,997 patients), and 3 diseased vessels with left main
stenosis (42, 492 patients). A multivariate logistic ana-
lysis of 32 risk factors was used to risk-adjust outcomes.
Importantly, crossovers from off-pump to on-pump were
analyzed on an intention-to-treat basis. The off-pump
group was more likely to be elderly people, women, and
have suffered a preoperative stroke or renal failure,
whereas the on-pump group were more likely to be dia-
betic, have a low ejection fraction congestive heart fail-
ure, more single and 2 vessel disease (34 % versus
19.6 %, P = <0.001), therefore requiring fewer grafts (3.04
versus 3.58, P = 0.001). The authors show a significant
reduction in operative mortality in the off-pump group,
as well as a highly significant reduction in overall
adverse cardiac events, permanent stroke, dialysis, re-
operation, prolonged ventilation, sternal wound infec-
tion, renal failure, and prolonged length of stay. These
results were consistent across anatomic groups, whether
patients had 1-2 vessels diseased, or 3 diseased vessels
with or without left main stenosis.
“Important” Meta-analysis
Wijeysundera et al. [25] reported on 37 randomized
controlled trials (n = 3,449 patients) and 22 risk-adjusted
(logistic regression or propensity-score) observational
studies (n = 293,617). The overall conversion rate was high
at 13 %.
When the authors studied closely the 37 RCTs, they
found that off-pump was associated with reduced atrial
fibrillation (OR 0.59) and trends toward reduced 30-day
mortality (OR 0.91), stroke (OR 0.52), and myocardial
infarction (OR 0.79).
The analysis of the Observational studies showed, off-
pump to be associated with reduced 30-day mortality
(OR 0.72), stroke (OR 0.62), infarction (OR 0.66), and
atrial fibrillation (OR 0.78). However, only atrial fibrilla-
tion reached statistically significance reduction in off
pump group in both RCTs and observational studies.
One can be critical when observing that the difference
in the incidence of stroke changed from statistically sig-
nificant to non-significant, when compare results from
observational studies to RCTs. This difference in find-
ings points to selection bias as a source of systematic
error in the meta-analyses that included observational
studies.
Finally at one to two years, off-pump was associated
with increased incidence of repeat revascularization.
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Moller et al. [26] reported on a meta-analysis of 66
randomized trials of off versus on pump, including 5202
patients. There were no statistically significant differences
between the two groups, regarding mortality [relative risk
(RR) 0.98; 95 % confidence interval (CI) 0.66–1.44], myo-
cardial infarction (RR 0.95; 95 % CI 0.65–1.37), or repeat
coronary revascularization (RR 1.34; 95 % CI 0.83–2.18).
There was a significant reduced risk of atrial fibrillation
(RR 0.69; 95 % CI 0.57–0.83) in the off-pump group.
Subsequently Moller [27] looked at 10 “low-bias” trials
(n = 4950) of a total of 86 RCTs comparing Off-pump
with On-pump surgery. The authors showed that off-
pump CABG increased all-cause mortality compared
with on-pump CABG; the effect was more pronounced
in the trials at low risk of bias: (6.2 %) off-pump versus
(4.6 %) on-pump, RR 1.35,95 % CI 1.07 to 1.70; P = .01).
This translates to a 30 % higher risk of all-cause mortal-
ity after off-pump CABG compared with on-pump
CABG.
Other adverse events like MI, stroke, renal insuffi-
ciency or repeat revascularization were similar despite a
slightly lower number of distal anastomoses Off-pump
versus On-pump. The report criticised, by the fact that
studies with high mortality following off pump surgery,
were included in this meta-analysis.
Feng et al. [28] reported on a meta-analysis of ten
randomized trials (2,018 patients) of off-pump versus
on-pump surgery. The primary outcome was defined as
all-cause mortality, stroke, myocardial infarction, and
revascularization at 1 year. Off-pump coronary artery
bypass surgery in this study did not differ from on-
pump surgery with regard to mortality, rates of stroke,
myocardial infarction, or revascularization.
Tagaki et al. [29] performed an updated meta-analysis
of graft patency after off-pump versus on-pump CABG
from randomized trials. This meta-analysis included data
on 6898 grafts and suggests that off- pump CABG may
increase overall graft occlusion by 32 %, over on-pump
CABG.
The same group [30] went on to look as to whether
off versus on pump techniques have any influence on
mid term MACCE. Eight RCTs enrolling 10 954 patients
were identified and included. A pooled analysis demon-
strated no statistically significant difference in off-pump
and on-pump CABG (hazard ratio, 1.10; 95 % confi-
dence interval, 0.93-1.29; P = 0.27). The authors con-
cluded that off-pump CABG appears not to increase
mid-term MACCE over on-pump CABG.
Attaran et al. [31] reported in a meta analysis looking
into whether off-pump coronary artery bypass improves
outcomes when compared to on-pump coronary artery
bypass in the female population. A systematic literature
review identified six observational studies, incorporating
23313 patients (n = 9596 OPCAB, 13717 ONCAB). 30-
day mortality was similar between the two techniques
therefore the authors concluded that off pump is a safe
alternative to on pump in the surgical revascularisation
of female patients.
Chen et al. [32] did a meta-analysis of 43 randomized
clinical trials with 8104 patients in the off-pump group
and 8724 cases in the on-pump group. The meta-
analyses of these trials showed no significant difference
between off-pump and on-pump in the incidences of
stroke (odds ratio (OR) = 0.80, 95 % confidence interval
(CI) = 0.52 - 1.22, P = 0.30) and MI (OR = 0.73, 95%CI =
0.52 - 1.02, P = 0.06). However, there was a significantly
reduced risk of AF (OR = 0.65, 95%CI = 0.52 - 0.82, P =
0.0002) in off-pump patients.
Godinho et al. [33] reported on nine randomized clinical
trials, corresponding to a total of 75,086 patients, and
compared off-pump to on-pump. A reduction of 18 % in
the risk of cardiovascular mortality (OR: 0.82, 95%CI: 0.70
to 0.98, p = 0.03) and 27 % in the risk of stroke postopera-
tively (OR: 0.73, 95%CI: 0.63 to 0.85, p = 0.0001) were
observed, both in favor of off-pump. Concerning the oc-
currence of complications associated with the procedure,
no significant differences were found between the two sur-
gical techniques, particularly with regard to the occur-
rence of renal complications (OR: 0.97, 95%CI: 0.84-1.14,
p = 0, 74) and sepsis (OR 0.98, 95%CI: 0.64-1.51, p = 0.93,
respectively).
An important meta-analysis, using propensity score
analyses, reported by Kuss et al. [34]; 123,137 patients
were included in this report. The estimated overall odds
ratio was less than 1 for all outcomes, favouring off-
pump surgery. This benefit was statistically significant
for mortality (odds ratio 0.69; 95 % confidence interval,
0.60–0.75), stroke, renal failure, red blood cell transfu-
sion (P < .0001), wound infection (P < .001), prolonged
ventilation (P <0.01), inotropic support (P < .02), and
intra-aortic balloon pump support (P < .05). The odds
ratios for myocardial infarction, atrial fibrillation, and re-
operation for bleeding were not significant.
A much smaller meta-analysis of randomized trials by
Takagi and colleagues [35] focused on a late (>1 year) all
caused mortality of off-pump versus on pump; the au-
thors concluded that off-pump may increase late all-
cause mortality by a factor of 1.37 over on-pump CABG.
A meta-analysis published by Afilalo et al. [36] in-
cluded all published and unpublished RCTs of Off-pump
versus On-pump CABG from the MEDLINE, EMBASE
and Cochrane databases. This report, took into consider-
ation a total of 59 trials, encompassing 8961 patients.
There was a significant 30 % reduction in post-operative
strokes with Off-pump surgery [risk ratio (RR) 0.70,
95 % CI: 0.49–0.99]. There was no significant difference
in mortality (RR: 0.90, 95 % CI: 0.63–1.30) or MI (pooled
RR: 0.89, 95 % CI: 0.69–1.13). In the meta-regression
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analysis, the effect of Off-pump on all of the clinical out-
comes was similar regardless of mean age, proportion of
females in the trial, number of grafts per patient, and
trial publication date.
Sa et al. [37] looked and reported at Forty-seven RCTs
included 13,524 patients (6,758 for off-pump and 6,766
for on-pump CABG). There was no significant difference
between off-pump and on-pump CABG groups in RR
for 30-day mortality or myocardial infarction. However
Off-pump CABG found to reduce the incidence of post-
operative stroke by 20.7 %.
Table 1, is depicting the most important publications
on Off-Pump vs. On-pump argument; the reported stud-
ies are matched with the Level of evidence and key re-
sults of each individual study is given.
Limitations
The lack of consistency of outcomes is primarily arising
from the observational nature of the majority of the
studies. The decision to advocate beating heart surgery
has been infrequently influenced by selection bias. In
some surgical series, beating-heart bypass has been pref-
erentially adopted when good quality target vessels were
present. This aspect has heavily biased results and has
been heavily criticized.
Propensity matching has eliminated some of the con-
founding. Furthermore, some studies by using large da-
tabases were able to adjust for many important risk
factors. There are 2 caveats during construction of a
meta-analysis that are worth mentioned: The criticism
on large meta-analysis scale reports lies on the fact that
when observational studies are included then the results
are skewed due to confounding factors; secondly the
methodology of the meta-analysis can be appreciated in
this example: if you include RCTs with no strokes you
may find no significant association between off-pump
and stroke rate; if you exclude RCTs with no strokes you
may find off-pump to be associated with a significantly
lower incidence of stroke than on-pump CABG.
It can be argued that excluding a large number of
RCTs, with no reported strokes in either arm of the trial,
inflates the size of the treatment effect, producing a
falsely significant statistical result. Alternatively, by in-
cluding zero event RCTs, the size of the treatment effect
is unjustifiably diluted and this produces a falsely non-
significant result. It is encouraging however that treat-
ment effects from RCTs and propensity score analyses
were very similar in a "meta-matched" population of
studies; the estimated differences in "meta-odds ratios"
were below an absolute value of 0.15, indicating that
only a small remaining bias is present in propensity
score analyses.
Finally, most trials comparing Off with On-pump sur-
gery have excluded high-risk patients; by excluding this
Table 1 The most important publications on Off-Pump vs. On-
pump, matched with the appropriate “Level of evidence” and “key
results” of each individual study
Author Patient Group, study type/Level of Evidence Outcomes & Key
Results
Important Randomized Control Trials (RCTs)
[1] Angelini G et al,
Lancet (2002)
RCT, (BHACAS 1) Less AFib, Inotrop use,
Transfusions and












200 pts Off pump vs.
201 pts on pump








[2] Ascione R et al,
European heart
journal (2004)
RCT, (BHACAS 2) Both groups showed a
similar deterioration of
the “quality of life
scoring systems” with
time.
200 pts Off pump vs.
201 pts on pump
Aim to assess disease
specific quality of life
at mid-term follow up.
[3] Angelini G et al, J
Thorac Cardiovasc
Surg (2009)
6 to 8 years follow up
of the BHACAS pts.








(11.0 %) groups (odds
ratio, 1.00; 95 % confi-
dence interval, 0.55-
1.81; P > .99).





off-pump and on pump
groups in the hazard of
death (hazard ratio,
1.24; 95 % confidence
interval, 0.72-2.15) or
MACCE (hazard ratio,
0.84; 95 % confidence
interval, 0.58-1.24)
[4] Nathoe HM et al, N
Engl J Med (2003)
Multicenter RCT. Graft patency was
similar and above
90 % in both groups.
Freedom from MACCE
was 90 %, somehow
similar between the
two groups. At 1 year






disease. 140 pts either
arm of the study.
Graft patency, MACCE
and cost-effectiveness
in 1 year following sur-
gery, was reported.
[5] Puskas J et al, J
Thorac Cardiovasc
Surg (2003)





Parissis et al. Journal of Cardiothoracic Surgery  (2015) 10:185 Page 7 of 14
Table 1 The most important publications on Off-Pump vs. On-
pump, matched with the appropriate “Level of evidence” and “key
results” of each individual study (Continued)
200 unselected,
elective CABGs were
randomly assign to Off
vs. On pump.












[6] Puskas J et al,
JAMA (2004)




the 2 groups at
30 days and 1 year. Off




in 30 days and 1 year
following surgery was
reported.
[7] Puskas J et al, Ann
Thorac Surg (2011)
7.5 year Follow-up of
the above RCT.
Mortality, around 30 %
at 7.5 years in both
groups.













2.3 % at 7.5 years in
both groups.
[8] Legare JF et al,
Circulation (2004)





300 pts divided into
two equal arms. Pts







[9] Al-Ruzzeh et al,
BMJ (2006)
Single-centre RCT. Similar graft patency
between the two








were carried out at
baseline and at six







at six weeks and two
memory subtests at six
months in favor of the
off-pump group.
[10] ROOBY Trial, N
Engl J Med (2009)
Multi-centre RCT. Similar 30-day composite
outcome around 6-7 %.
One year composite
outcome 9.9 % off-
pump vs. 7.4 % on-










Table 1 The most important publications on Off-Pump vs. On-
pump, matched with the appropriate “Level of evidence” and “key












of 82.6 % off-pump
vs. 87.8 % on-pump,
P < 0.01.
[11] Moller CH et al,
Circulation (2010)
Single-centre RCT. Fewer grafts were
performed to the








SCORE > or = 5).
Interestingly, pts with





outcome (15 % vs.
17 %; P = 0.48) or the
individual components








[12] Moller CH et al,
Heart (2011)




in the off-pump group
(24 % vs. 15 %; HR
1.66, 95 % CI 1.02 to
2.73; p = 0.04), but
cardiac-related death
was not significantly
different (10 % vs. 7 %;
HR 1.30, 95 % CI 0.64
to 2.66; p = 0.47). I am
wondering, if that
reflects a sicker general






[13] Houlind et al, J
Thorac Cardiovasc
Surg. (2014)
DOORS Trial. The proportion of
open left internal
thoracic artery grafts
was 95 % in both
groups. However, vein
graft patency after off-
pump surgery was









[14] Lamy A et al,
American Heart
Journal (2012)
CORONARY Trial The primary short-term
end point was a com-




coma, stroke, or renal
failure) before discharge
or within 30 days after
surgery. The primary
long-term end point
was a composite of




to On versus Off
pump.
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Table 1 The most important publications on Off-Pump vs. On-
pump, matched with the appropriate “Level of evidence” and “key
results” of each individual study (Continued)
revascularization
procedure, or a nonfatal





patency at 1 year and
neuropsychological
outcomes.
[15] Lamy A et al, N
Engl J Med (2012)
CORONARY Trial. No significant








CABG with respect to
the 30-day mortality,
MI, stroke, or renal
failure requiring dialy-






tions, and acute kidney
injury at the expense
of an increased risk of
early revascularization.
Early report of 30 days
primary outcomes
[16] Lamy A et al, N
Engl J Med (2013)
CORONARY Trial. No difference in the





[17] Diegeler A et al,





versus off pump. The
primary end point was





therapy at 30 days and











pump CABG than after
on-pump CABG (1.3 %
vs. 0.4 %; odds ratio,
2.42; 95 % CI, 1.03 to
5.72; P = 0.04). points.
[18] Vieira de Melo RM
et al, Eur J
Cardiothorac Surg
(2014)
5 year follow up of the
















the ROOBY Trial. 835
The 1-year graft
patency was lower
Table 1 The most important publications on Off-Pump vs. On-
pump, matched with the appropriate “Level of evidence” and “key
results” of each individual study (Continued)











on the off-pump CABG
group.
Large Observational studies
[20] Cleveland JC et al,
Ann Thorac Surg
(2001)
STS Database. Operative mortality
2.3 % for off-pump vs.
2.9 % with on-pump,
P < 0.001.





MACCE 10.62 % for off-
pump vs. 14.15 % with
on-pump, P < 0.001.





1997 to 2000 in the
state of New York.
Mortality was 2.02 %
for off-pump vs.
2.16 % for on-pump
(p = 0.390)





(1.6 % vs. 2.0 %,
p = 0.003)










survival benefit from on-
pump procedures was
no longer present in the
last two years of the
study.
[22] Mack M et al, J
Thorac Cardiovasc
Surg (2004)




significantly less in the
off-pump coronary
artery bypass grafting
group (2.8 % vs. 3.7 %,
P < .001).






transfusion (32.6 % vs.
40.6 %, P < .001), stroke
(1.4 % vs. 2.1 %,
P = .002), renal failure
(2.6 % vs. 5.2 %, P
< .001), pulmonary
complications (4.1 %
vs. 9.5 %, P < .001),
reoperation (1.7 % vs.
3.2 %, P < .001), atrial
fibrillation (21.1 % vs.
24.99 %, P < .001).
[23] Hannan EL et al,
Circulation (2007)
New York Database







95 % confidence inter-
val [CI] 0.68 to 0.97)
and lower rates for 2
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Table 1 The most important publications on Off-Pump vs. On-
pump, matched with the appropriate “Level of evidence” and “key
results” of each individual study (Continued)
complications (stroke:
adjusted OR 0.70, 95 %
CI 0.57 to 0.86; respira-
tory failure: adjusted
OR 0.80, 95 % CI 0.68
to 0.93).
What became







95 % CI 1.33 to 1.80).
This could be
potentially explained
by the fact that Off-
pump pts may have






[24] Puskas J et al,
45th STS Annual
Meeting (2009)
STS database. There was a significant
reduction in operative
mortality in the off-
pump group, as well










et al, Journal Of
American College Of
Cardiology (2005)
A meta-analysis of 37
randomized controlled






In RCTs, Off-pump was
associated with re-
duced atrial fibrillation
(OR 0.59; 95 % CI 0.46
to 0.77) and trends to-
ward reduced 30-day
mortality (OR 0.91
95 % CI 0.45 to 1.83),
stroke (OR 0.52; 95 %
CI 0.25 to 1.05), and
myocardial infarction






tality (OR 0.72; 95 % CI
0.66 to 0.78), stroke
(OR 0.62; 95 % CI 0.55
to 0.69), infarction (OR
0.66; 95 % CI 0.50 to
0.88), and atrial fibrilla-
tion (OR 0.78; 95 % CI
0.74 to 0.82).
At 2 years off-pump
was associated with in-
crease repeat revascu-
larization procedures.









of atrial fibrillation (RR
Table 1 The most important publications on Off-Pump vs. On-
pump, matched with the appropriate “Level of evidence” and “key
results” of each individual study (Continued)
0.69; 95 % CI 0.57-
0.83).
[27] Moller CH et al 10 “low-bias” RCTs,
4950 pts.


































occlusion by 32 %.












[31] Attaran S et al,
Perfusion (2014)










23313 patients (n = 9596
Off pump, 13717 On
pump).





trials were selected for
meta-analysis with
8104 patients in the
Off-pump group and




reduces the risk of
postoperative AF com-
pared with On-pump,
but there is no signifi-
cant difference in the
incidences of stroke
and MI between the
two procedures.









A reduction of 18 % in
the risk of
cardiovascular mortality
(OR: 0.82, 95%CI: 0.70 to
0.98, p = 0.03) and 27 %
in the risk of stroke
postoperatively (OR:
0.73, 95%CI: 0.63 to
0.85, p = 0.0001) were
observed, both in favor
of Off-Pump Surgery.
[34] Kuss O et al, J
Thorac Cardiovasc
Surg (2010)
A Meta-analysis of a
total of 35 propensity
score analyses was in-
cluded in this study
This study favors off-
pump with lower
mortality (odds ratio,
0.69; 95 % confidence
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group from trials, the full potential of off-pump work is
yet to be elucidated.
Discussion
Extensive literature had been published on the subject of
off pump coronary artery bypass surgery. With lack of
robustness in the current evidence, more questions had
been raised and there is currently still a controversy in
its effectiveness and indication.
As a result, Off- pump surgery has fallen out of fash-
ion in Europe and United States. Only in Japan there is
consistency in off-pump practise; The Annual report of
Japanese Association for Thoracic Surgery publishes
high numbers of off-pump CABG performance in more
than 60 % of cases, steadily over the last 10 years [38].
To summarize, we can deduce that both techniques
confers similar early graft patency and in turn, similar
clinical outcome up to 1 year. However, controversies
still exist in terms of long-term clinical outcome and
angiographic grafts patency.
The high occlusion rate of grafts in off-pump surgery
must be due to high occlusion rate of saphenous veins
in addition to technical difficulty. Poor graft patency and
poor long-term results in off-pump surgery were related
to higher venous occlusion rate because of the hyperco-
agulability status after surgery, in at least three reported
studies [39–41].
The largest randomized control trial so far brought
out more arguments than answers, by recruiting low risk
patients that would be benefit by either technique. Lar-
ger meta-analyses and databases are better powered to
compare outcomes and in general have shown more
favourable in-hospital outcomes especially in riskier pa-
tients and equivalent long-term outcomes with off-pump
compared to on-pump coronary artery bypass. Further-
more the benefits of off-pump techniques may be more
apparent for patients at high risk for complications asso-
ciated with the global ischemia of cardioplegic arrest and
aortic manipulation.
So, who’s benefit from off-pump surgery; taken from
the literature thus far, we can deduce that both tech-
niques confers similar early graft patency and in turn,
similar clinical outcome up to 1 year.
Completeness of revascularization with off pump tech-
niques has been questioned and thus higher re-intervention
rate has been reported in various studies. However one has
to take into account the effect on volume-outcome rela-
tionship, which exists for morbidity and mortality after off-
pump surgery with a threshold of more than 50 operations
per year.
Is off-pump surgery beneficial to female gender? It
may be a trend towards that but it remains to be
seen.
Table 1 The most important publications on Off-Pump vs. On-
pump, matched with the appropriate “Level of evidence” and “key
results” of each individual study (Continued)




red blood cell transfu-
sion (P < .0001), wound
infection (P < .001),
prolonged ventilation
(P < .01), inotropic
support (P = .02), and
intraaortic balloon
pump support (P = .05).




(4,326 patients) of off-
pump vs. on-pump
CABG.
This study revealed a
statistically significant
increase in midterm
all-cause mortality by a
factor of 1.37 with off-
pump relative to on-
pump CABG (RR, 1.373;
95 % confidence inter-
val, 1.043 to 1.808).
This report focused on
late (> or = 1 year) all-
cause mortality.
[36] Afilalo J et al, Eur
Heart J (2012)
Meta analysis, Fifty-







reduced by 30 % on
the off pump group.











reduced by 20.7 % on
the off pump group.6,758 off-pump pts
and 6,766 on-pump
CABG pts.
Papers with important statements, on the argument: “On versus Off
Pump”
[38] Grover F, N Engl J
Med (2012)
Editorial An interesting editorial
that “reconciles” the
findings of the ROOBY
and CORONARY trials

















the balance one way
or the other
[41] Yadava O et al,
Indian Heart J (2013)
Real world experience,
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Off pump surgery reduces the incidence of postopera-
tive Atrial Fibrillation. This has been persistent in nu-
merous studies being supported by robust evidence.
The current weight of evidence from systematic reviews
and meta-analyses favours the position that off-pump may
reduce the incidence of a stroke; Furthermore it has be-
come apparent that non touch off-pump techniques are
associated with significant reduction of the incidence of a
stroke, down to less that 0.5 %.
There are numerous studies to suggest that early mor-
bidity and mortality is reduced in high-risk patients when
off-pump techniques are implemented. That may include
patients with reduced EF or severe lung, renal or vascular
dysfunction. Therefore, the benefits of off-pump tech-
niques may be more apparent in patients at high risk for
complications associated with the global ischemia of car-
dioplegic arrest and aortic manipulation.
They may be a trend towards less postoperative com-
plications in octagenarians undergone off-pump surgery;
however the up till now studies suggested that there is
no survival benefit attributed to off-pump surgery.
Conversion to on-pump is associated with adverse out-
come. Moreover during emergency conversion there has
been observed a fivefold increased in mortality and a
higher rate of postoperative complications.
The investigators from the ROOBY trial are recom-
mending either of the two techniques based on patient
factors, provided the surgeon was competent in both.
For example, if a patient had renal dysfunction or a
heavily calcified aorta, off pump would be preferred.
Hattler et al. reported the 1-year angiographic follow-
up of the “ROOBY cohort” (AHA Congress, Orlando,
2014). The authors revealed that off-pump patients had
a lower saphenous vein patency than on-pump, but a
similar arterial graft patency rate, leading to less effective
revascularization.
Grover [42] in an editorial tried to reconcile the differ-
ence between the ROOBY and CORONARY trial find-
ings. The author went on to say that the CORONARY
trial involved only surgeons experienced in Off-pump
surgery, whereas the ROOBY trial also had trainees as
operating surgeons. On a conservative note however, he
cautioned that any firm conclusions would have to await
long-term follow-up results.
The International Society for Minimally Invasive
Cardiothoracic Surgery (ISMICS) recommendations
[43] state that the use of Off-pump bypass reduces peri-
operative morbidity, neurocognitive dysfunction and
hospital length of stay and should be considered espe-
cially in high-risk patients, for example, those with se-
vere ascending aortic calcification, liver disease, renal
insufficiency or other systemic processes that may be
exacerbated by CPB, in order to reduce morbidity and
mortality.
In 2011 the AHA published a balanced and sensible ap-
proach on the argument, of “On-pump versus off-pump”
[44]. Based on available data, the guidelines contend, both
approaches are reasonable, with certain factors tilting the
balance one way or the other.
Conclusions
In summary, although off-pump surgery, maybe produces
comparable results to on pump surgery, certain groups of
patients such patients with severely calcified aorta, high
risk patients with severe end organ dysfunction and pos-
sibly patients undergoing hybrid revascularization proced-
ure with PCI and Off-pump combination; and finally
selected patients requiring redo surgery in an effort to po-
tentially reduce the morbidity associated with on-pump
techniques.
The “real world” experience with off-pump surgery
comes from the National Heart Institute in Delhi [45] of
over 5000 cases done Off-pump with an impressive con-
version rate of less than 1 % and mortality of 1.6 %; this
shows that off pump is an effective and safe technique,
provided it is adopted and practiced properly. The best
technique is that which works best for that particular pa-
tient, in the context of his clinical setting and his treating
surgeon's repertoire lending credence to the belief that it
is the surgeon and not the technique, which is at the heart
of the problem.
As the superiority of off-pump is presently confined at
high-risk patients with severe ascending aortic calcifica-
tion, liver disease, and renal insufficiency, the merits of
this technique is narrowed down to less than 10 % of
total CABG population who really benefit from off-
pump. However cardiac surgeons who are called to per-
formed off-pump CABG surgery in less than 10 % of
CABG cases (which are also technically demanding),
they will be facing with a massive challenge. In order to
overcome the difficulties and learning curves under
stressful circumstances, daily off -pump exercise may be-
come mandatory training so eventually the surgeon will
safely perform sophisticated off pump CABG surgery
such as aortic non-touch total arterial revascularization.
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